Search research articles
Contact Us
Filters
Showing results (571-580 of 664) with videos related to
Page
of 67
Sort By:
The Oncologist
|
April 1, 2026
Time dependent outcomes modeling in a real-world analysis of the molecular tumor board at university cancer center Hamburg (2016-2022)
Janna-Lisa Velthaus-Rusik, Jan Frederic Weller, Melisa Hoshaber, et al.
Journal of Natural Products
|
November 22, 2022
Meroantarctines A-C, Meroterpenoids with Rearranged Skeletons from the Alga-Derived Fungus <i>Penicillium antarcticum</i> KMM 4685 with Potent p-Glycoprotein Inhibitory Activity
Elena V Leshchenko, Alexandr S Antonov, Sergey A Dyshlovoy, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 11, 2020
Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'
Benedikt C Westphalen, Carsten Bokemeyer, Reinhard Büttner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3
Eric Van Cutsem, Roberto Labianca, György Bodoky, et al.
Oncotarget
|
November 10, 2018
Multi-omic based molecular profiling of advanced cancer identifies treatable targets and improves survival in individual patients
Alexandra Samsen, Silvia von der Heyde, Carsten Bokemeyer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 29, 2026
Mapping the anatomical landscape of colorectal tumours: Location-specific efficacy of anti-epidermal growth factor receptor antibodies: Pooled analysis of randomised trials
Kenta Iguchi, Kentaro Yamazaki, Toshihiro Misumi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 16, 2022
Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer ≥ 70 years
Demetris Papamichael, Guilherme S Lopes, Curt L Olswold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 20, 2008
Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie
Salah-Eddin Al-Batran, Joerg Thomas Hartmann, Stephan Probst, et al.
Scientific Reports
|
August 9, 2022
New diterpenes from the marine sponge Spongionella sp. overcome drug resistance in prostate cancer by inhibition of P-glycoprotein
Sergey A Dyshlovoy, Larisa K Shubina, Tatyana N Makarieva, et al.
International Journal of Molecular Sciences
|
December 11, 2022
Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer
Gunhild von Amsberg, Mirjam Zilles, Wael Mansour, et al.
Page
of 67
Search research articles
Search
Showing results (571-580 of 664) with videos related to
Sort By:
Page
of 67
The Oncologist
|
April 1, 2026
Time dependent outcomes modeling in a real-world analysis of the molecular tumor board at university cancer center Hamburg (2016-2022)
Janna-Lisa Velthaus-Rusik, Jan Frederic Weller, Melisa Hoshaber, et al.
Journal of Natural Products
|
November 22, 2022
Meroantarctines A-C, Meroterpenoids with Rearranged Skeletons from the Alga-Derived Fungus <i>Penicillium antarcticum</i> KMM 4685 with Potent p-Glycoprotein Inhibitory Activity
Elena V Leshchenko, Alexandr S Antonov, Sergey A Dyshlovoy, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 11, 2020
Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'
Benedikt C Westphalen, Carsten Bokemeyer, Reinhard Büttner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3
Eric Van Cutsem, Roberto Labianca, György Bodoky, et al.
Oncotarget
|
November 10, 2018
Multi-omic based molecular profiling of advanced cancer identifies treatable targets and improves survival in individual patients
Alexandra Samsen, Silvia von der Heyde, Carsten Bokemeyer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 29, 2026
Mapping the anatomical landscape of colorectal tumours: Location-specific efficacy of anti-epidermal growth factor receptor antibodies: Pooled analysis of randomised trials
Kenta Iguchi, Kentaro Yamazaki, Toshihiro Misumi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 16, 2022
Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer ≥ 70 years
Demetris Papamichael, Guilherme S Lopes, Curt L Olswold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 20, 2008
Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie
Salah-Eddin Al-Batran, Joerg Thomas Hartmann, Stephan Probst, et al.
Scientific Reports
|
August 9, 2022
New diterpenes from the marine sponge Spongionella sp. overcome drug resistance in prostate cancer by inhibition of P-glycoprotein
Sergey A Dyshlovoy, Larisa K Shubina, Tatyana N Makarieva, et al.
International Journal of Molecular Sciences
|
December 11, 2022
Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer
Gunhild von Amsberg, Mirjam Zilles, Wael Mansour, et al.
Page
of 67